Differential Laboratory Diagnosis of Hypercalcemia

References

• Toffaletti J., McComb R. B., Bowers G. N., Jr. Increase in dialyzable calcium associated with therapy with lithium. Clin. Chem. 1979; 25: 1806
   PubMedGoogle Scholar
• Josephson B., Dahlberg G. Variations in the cell content and chemical composition of human blood due to age sex and season. Scand. J. Clin. Lab. Invest. 1952; 4: 216
   PubMed Web of Science ®Google Scholar
• McLean F. C., Hastings A. B. Chemical estimation and significance of calcium ion concentrations in the blood. Am. J. Med. Sci. 1935; 189: 601
   Google Scholar
• Kramer B., Tisdall F. F. The direct quantitative determination of sodium potassium and calcium and magnesium in small amounts of blood. Biol. Chem. 1921; 47: 475
   Google Scholar
• Clark E. P., Collip J. B. A study of the Tisdall method for the determination of blood serum calcium with a suggested modification. J. Biol. Chem. 1925; 63: 461
   Google Scholar
• Berger E. Y. Calcium determination in biologic material. Clin. Chem. 1955; 1: 249
   PubMed Web of Science ®Google Scholar
• Bachra B. N., Dauer A., Sobel A. E. The complexometric titration of micro and ultramicro quantities of calcium in blood serum urine and inorganic salt solutions. Clin. Chem. 1958; 4: 107
   PubMedGoogle Scholar
• Kesler G., Wolfman M. An automated procedure for the simultaneous determination of calcium and phosphorus. Clin. Chem. 1964; 10: 686
   PubMedGoogle Scholar
• Flynn F. V., Piper K. A. J., Garcia-Webb P., McPherson K., Healy M. J. R. Biological and analytical variation of commonly determined blood constituents in healthy blood donors. Clin. Chim. Acta 1976; 70: 179
   PubMedGoogle Scholar
• Barrett A. E., Cameron S. J., Frazer C. G., Penberthy L. A., Shand K. L. A clinical view of analytical goals in clinical biochemistry. J. Clin. Pathol. 1979; 32: 893
   PubMedGoogle Scholar
• Hald P. M., Eisenman A. J. The distribution of bases between cells and serum of normal human blood. J. Biol. Chem. 1937; 118: 275
   Google Scholar
• Stuzman F., Amatuzio D. S. A study of serum and spinal fluid calcium and magnesium in normal humans. Arch. Biochem. Biophys. 1952; 39: 271
   PubMedGoogle Scholar
• Sunderman F. W. Studies of serum electrolytes. The total base and protein components of the serum during lobar pneumonia with a note on the gastric secretion. J. Clin. Invest. 1931; 9: 615
   PubMedGoogle Scholar
• Wootton I. D. P., King E. J. Normal values for blood constituents. Inter-hospital differences. Lancet 1953; 4: 470
   Google Scholar
• Burke M. D. Calcium and phosphorus studies. Interpretation of results and strategies for further testing. Postgrad. Med. J. 1980; 68: 69
   Google Scholar
• Kelly A., Munan L., Petit Clare C., Ping Ho K., Billon B. Use of values for calcium and protein in serum and of a derived index obtained from a probability population sample. Clin. Chem. 1976; 22: 1723
   PubMed Web of Science ®Google Scholar
• Monchik J. M., Martin H. F. Ionized calcium in the diagnosis of primary hyperparathyroidism. Surgery 1980; 88: 185
   PubMedGoogle Scholar
• Conceicao S. C., Weightaman D., Smith P. A., Luno J., Ward M. K., Kerr D. N. S. Serum ionised calcium concentration: measurement vs. calculation. Br. Med. J. 1978; 1: 1103
   PubMed Web of Science ®Google Scholar
• Pederson K. O. Protein bound calcium in human serum. Quantitative examination of binding and its variables by a monecular binding model and clinical chemical implications for the measurement of molecular ionised calcium. Scand. J. Clin. Lab. Invest. 1972; 30: 321
   PubMed Web of Science ®Google Scholar
• Duncan P. H., Wills M. R., Smith B. J., Savory J. Clinical studies of protein bound calcium in various diseases. Clin. Chem. 1982; 28: 672
   PubMedGoogle Scholar
• Payne R. B., Little A. J., Williams R. B., Milner J. R. Interpretation of serum calcium in patients with abnormal serum proteins. Br. Med. J. 1973; 4: 643
   PubMed Web of Science ®Google Scholar
• Berry E. M., Gupta M. M., Turner S. J., Burns R. R. Variation in plasma calcium with induced changes in plasma specific gravity, total protein and albumin. Br. Med. J. 1973; 4: 640
   PubMed Web of Science ®Google Scholar
• Orrell D. H. Albumin as an aid to the interpretation of serum calcium. Clin. Chim. Acta 1971; 35: 483
   PubMed Web of Science ®Google Scholar
• Larrson L., Ohman S. Serum ionized calcium and corrected total calcium in borderline hyperparathyroidism. Clin. Chem. 1978; 24: 1962
   PubMedGoogle Scholar
• Pain R. W., Phillips P. J. Adjustment of serum calcium for protein. Clin. Chem. 1976; 22: 282
   PubMedGoogle Scholar
• Payne R. B., Little A. J. Adjusting serum calcium for protein. Clin. Chem. 1976; 22: 933
   Google Scholar
• Payne R. B., Carver M. E., Morgan D. B. Interpretation of serum total calcium, effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in an individual. J. Clin. Pathol. 1979; 32: 56
   PubMed Web of Science ®Google Scholar
• Husdan H., Rapoport A., Locke S., Oreopoulos D. Effect of venous occlusion of the arm on the concentration of calcium in serum and methods for its compensation. Clin. Chem. 1974; 20: 529
   PubMed Web of Science ®Google Scholar
• Parfitt A. M. Chlorothiazide induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N. Engl. J. Med. 1969; 281: 55
   PubMed Web of Science ®Google Scholar
• Dent C. E. Some problems of hyperparathyroidism. Br. Med. J. 1962; 11: 1419
   Google Scholar
• Payne R. B., Walker B. E. Serum calcium. Lancet 1979; 1: 1248
   PubMedGoogle Scholar
• Poltgen P., Davis E. R. Why measure total serum Ca?. Clin. Chem. 1976; 22: 1752
   PubMedGoogle Scholar
• Shimerdiak W. P., Kukreja C. S., Lad T. E., York P. A. J., Henderson W. J. Evaluation of routine ionised calcium determination in cancer patents. Clin. Chem. 1981; 27: 1621
   PubMedGoogle Scholar
• Ladenson J. H., Lewis J. W., Boyd J. C. Failure of total calcium corrected for protein albumin and pH to correctly assess free calcium status. J. Clin. Endocrinol. Metab. 1978; 46: 986
   PubMed Web of Science ®Google Scholar
• Lloyd A. M., Rose G. A. Ionized, protein-bound, and complexed calcium in primary hyperparathyroidism. Lancet 1958; 2: 1258
   PubMed Web of Science ®Google Scholar
• Low J. C., Schaaf M., Earll J. M., Piechocki J. T., Ting-Kai Li. Ionic calcium determination in primary hyperparathyroidism. JAMA 1973; 223: 152
   PubMed Web of Science ®Google Scholar
• Edmonson J. W., Ting-Kai Li. The relationship of serum ionized and total calcium in primary hyperparathyroidism. J. Lab. Clin. Med. 1976; 87: 624
   PubMedGoogle Scholar
• Bergman L., Isaaksson B. Plasma calcium fractions in normal subjects from birth to adult ages. Acta Paediatr. Scand. 1997; 60: 630
   Google Scholar
• Butler S. J., Payne R. B. Nova 2 Ionised calcium analyzer, imprecision, bias and protein interference. Clin. Chem. 1983; 29: 585
   PubMedGoogle Scholar
• Farr H. W. Hyperparathyroidism and cancer. CA; Cancer J. Clin. 1976; 20: 66
   Google Scholar
• Heath H., III, Hodgson S. F., Kennedy M. A. Primary hyperparathyroidism. Incidence morbidity and potential economic impact on a community. N. Engl. J. Med. 1980; 302: 189
   PubMed Web of Science ®Google Scholar
• Boonstra C. E., Jackson C. E. Hyperparathyroidism detected by routine serum calcium analysis. Prevalence in a clinic population. Ann. Intern. Med. 1965; 63: 468
   PubMed Web of Science ®Google Scholar
• Christensson T., Hellstrom K., Wengle B., et al. Prevalence of hypercalcemia in health screening in Stockholm. Acta Med. Scand. 1976; 200: 131
   PubMedGoogle Scholar
• Mundy G. R., Cove D. H., Fisken R. Primary hyperparathyroidism changes in the pattern of clinical presentation. Lancet 1980; 1: 1317
   PubMed Web of Science ®Google Scholar
• Johnson K. R., Howarth A. T., Hamilton M., Mascall G. C. Laboratory differentiation of hypercalcemic patients. Clin. Chem. 1982; 28: 333
   PubMedGoogle Scholar
• Boonstra C. E., Jackson C. E. Serum calcium survey for hyperparthyroidism. Am. J. Clin. Pathol. 1971; 55: 523
   PubMedGoogle Scholar
• Coe F. L., Favus J. Does mild asymptomatic hyperparathyroidism require surgery?. N. Engl. J. Med. 1980; 302: 224
   PubMed Web of Science ®Google Scholar
• Strott C. A., Nugent C. A. Laboratory tests in the diagnosis of hyperparathyroidism in hypercalcemic patients. Ann. Intern. Med. 1968; 68: 188
   PubMedGoogle Scholar
• Heath D. A., Wright A. D., Oates G. D., Dorricott W. J. Surgical treatment of primary hyperparathyroidism in the elderly. Br. Med. J. 1980; 280: 1406
   PubMedGoogle Scholar
• Christensson T., Hellstrom K., Wengle B., et al. Blood pressure in subjects with hypercalcemia and primary hyperparathyroidism detected in a health screening programme. Eur. J. Clin. Invest. 1977; 7: 109
   PubMed Web of Science ®Google Scholar
• Lafferty F. W. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension and discriminant analysis of laboratory tests. Arch. Intern. Med. 1981; 141: 1761
   PubMed Web of Science ®Google Scholar
• Kaplan R. A., Snyder W. H., Stewart A., et al. Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1976; 42: 415
   PubMed Web of Science ®Google Scholar
• Alveryd A., Bostrom H., Wengle B., Webster P. O. Indications for surgery in the elderly patient with primary hyperparathyroidism. Acta Chir. Scand. 1976; 142: 491
   PubMedGoogle Scholar
• Hecht A., Gershberg H., St. Paul H. Primary hyperparathyroidism. Laboratory and clinical data in 73 cases. JAMA 1975; 233: 519
   PubMedGoogle Scholar
• Editorial. Diagnosis and treatment of primary hyperparathyroidism. Lancet 1980; 1: 1339
   PubMedGoogle Scholar
• Purnell D. C., Scholz D. A., Smith L. H., et al. Treatment of primary hyperparathyroidism. Am. J. Med. 1974; 56: 800
   PubMed Web of Science ®Google Scholar
• Raisz L. G. The diagnosis of hyperparathyroidism. N. Engl. J. Med. 1971; 285: 1006
   PubMedGoogle Scholar
• Eisenberg E., Gotch C. Normocalcemic hyperparathyroidism culminating in hypercalcemic crisis; treatment with haemodialysis. Arch. Intern. Med. 1968; 122: 258
   PubMedGoogle Scholar
• Posen S., Kleerekoper M., Ingham J. P., Hirshorn J. E. Parathyroid hormone assay in clinical decision making. Br. Med. J. 1976; 1: 16
   PubMedGoogle Scholar
• Gutman A. B., Tyson T. L., Gutman E. B. Serum calcium inorganic phosphorus and phosphatase activity in hyperparathyroidism. Paget's disease, multiple myeloma and neoplastic disease of the bones. Arch. Intern. Med. 1936; 57: 379
   Google Scholar
• Woodard H. W. Changes in blood chemistry associated with carcinoma metastatic to bone. Cancer 1953; 6: 1219
   PubMedGoogle Scholar
• Kleinfeld G. Acute fatal hypercalcemia. JAMA 1962; 181: 1137
   PubMedGoogle Scholar
• Swaroop S., Krant M. J. Rapid estrogen-induced hypercalcemia. JAMA 1973; 223: 913
   PubMed Web of Science ®Google Scholar
• Warwick O. H., Yendt E. R., Olin J. A. The clinical features of hypercalcemia associated with malignant disease. Can. Med. Assoc. J. 1961; 85: 719
   PubMed Web of Science ®Google Scholar
• Goldberg M. F., Tashjian A. H., Order S. E., Dammin G. J. Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemia. Am. J. Med. 1964; 36: 805
   PubMed Web of Science ®Google Scholar
• Lafferty F. W. Pseudohyperparathyroidism. Medicine 1966; 45: 247
   PubMed Web of Science ®Google Scholar
• Gordan G. S., Eisenber E., Loken H. F., et al. Clinical endocrinology of parathyroid hormone excess. Recent Prog. Horm. Res. 1962; 18: 297
   Google Scholar
• Chopra D. P. Hypercalcemia and malignant disease. Med. Clin. N. Am. 1975; 59(2)
   Google Scholar
• Lee D. B. N., Zawada E. T., Kleeman C. R. The pathophysiology and clinical aspects of hypercalcemia disorders (medical progress). Est. J. Med. 1978; 129: 278
   Google Scholar
• Thomas A. N., Loken H. F., Gordan G. S., et al. Hypercalcemia of metastatic breast cancer. Surg. Forum 1960; 11: 70
   PubMedGoogle Scholar
• Gardner B., Graham W. P., Gordon G. S., et al. Calcium and phosphate metabolism in patients with disseminated breast cancer. Effect of androgens and of prednisone. J. Clin. Endocrinol. 1963; 23: 115
   Google Scholar
• Jessiman A. G., Emersen J., Jr., Shar R. C., et al. Hypercalcemia in carcinoma of the breast. Ann. Surg. 1963; 157: 377
   PubMed Web of Science ®Google Scholar
• Bender R. A., Hansen H. Hypercalcemia in bronchogenic carcinoma. A prospective study of 200 patients. Ann. Intern. Med. 1974; 80: 205
   PubMed Web of Science ®Google Scholar
• Warren M. M., Utz D. C., Kelalis P. P. Concurrence of hypernephroma and hypercalcemia. Ann. Surg. 1971; 174: 863
   PubMed Web of Science ®Google Scholar
• Fisken R. A., Heath D. A., Bold A. M. Hypercalcemia—a hospital survey. Q. J. Med. New Ser. XLIX 1980; 196: 405
   Google Scholar
• McLellan G., Baird C. W., Melick R. Hypercalcemia in an Australian hospital adult population. Med. J. Aust. 1968; 2: 354
   PubMedGoogle Scholar
• Heath D. A. Hypercalcemia and malignancy. Ann. Clin. Biochem. 1976; 13: 555
   PubMed Web of Science ®Google Scholar
• Myers W. P. L. Hypercalcemia in neoplastic disease. Arch. Surg. 1960; 80: 308
   PubMed Web of Science ®Google Scholar
• Delamore I. W. Hypercalcemia and myeloma. Br. J. Haematol. 1982; 5: 507
   Google Scholar
• Albright F., Burnett C. H., Cope O., Parson W. Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J. Clin. Endocrinol. Metab. 1941; 1: 711
   Google Scholar
• Becker D. J., Sternberg M. S., Kalser M. H. Hepatoma associated with hypercalcemia. JAMA 1963; 186: 1018
   PubMed Web of Science ®Google Scholar
• Berson S. A., Yalow R. S. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia and bronchogenic carcinoma. Science 1966; 154: 907
   PubMed Web of Science ®Google Scholar
• Connor T. B., Thomas W. C., Howard J. E. Etiology of hypercalcemia associated with lung carcinoma. J. Clin. Invest. 1956; 35: 697
   Google Scholar
• Plimpton C. H., Gelhorn A. Hypercalcemia in malignant disease without evidence of bone destruction. Am. J. Med. 1956; 21: 750
   PubMed Web of Science ®Google Scholar
• Mavligit G. M., Cohen J. L., Sherwood L. Ectopic production of parathyroid hormone by carcinoma of the breast. N. Engl. J. Med. 1971; 285: 154
   PubMedGoogle Scholar
• Benson R. C., et al. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J. Clin. Invest. 1974; 54: 175
   PubMed Web of Science ®Google Scholar
• Jayaraman J., David R. Hypercalcemia as a presenting manifestation of leukemia: evidence of excessive parathormone secretion. J. Pediatr. 1977; 90: 60
   Google Scholar
• Libnoch J. A., Ajlouni K., Millman W. L., et al. Acute myelofibrosis and malignant hypercalcemia. Am. J. Med. 1977; 62: 432
   PubMed Web of Science ®Google Scholar
• Powell D., Murray T. M., Pollard J. J., et al. Parathyroid localization using venous catheterization and radioimmunoassay. Arch. Intern. Med. 1973; 131: 645
   PubMedGoogle Scholar
• Riggs B. L., Arnaud C. D., Reynolds J. C., Smith L. H. Immunological differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonhyperparathyroid cancer. J. Clin. Endocrinol. Metab. 1968; 28: 1037
   PubMedGoogle Scholar
• DiBella F. P., Kehrwald J. M., Laakso K., Zitner L. Parathyrin radioimmunoassay diagnostic utility of antisera produced against C terminal fragments of the hormone from the human. Clin. Chem. 1978; 24: 451
   PubMedGoogle Scholar
• Raisz L. G., Yandick C., Bockman R. S., Bower B. F. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism and malignancy. Ann. Intern. Med. 1979; 91: 739
   PubMedGoogle Scholar
• Almquist S., Hjern B., Wasthed B. The diagnostic value of radioimmunoassay for parathyroid in human serum. Acta Enocrinol. 1975; 78: 493
   PubMedGoogle Scholar
• Freaney R., Ryan E., Muldowney F. P. Differentiation of hypercalcemia due to malignancy from primary hyperparathyroidism: the value of parathyroid hormone and plasma bicarbonate measurements. Ir. J. Med. Sci. 1981; 150: 6
   PubMedGoogle Scholar
• Heath D. A., Aurbach C. D. Ectopic production of parathyroid hormone: a prototype of a non-endocrine hormone synthesis. Endocrinology and Diabetes, L. J. Kryston, R. A. Shaw. Grune & Stratton, New York 1975; 215
   Google Scholar
• Bockman R. S. Hypercalcemia in malignancy. Clin. Endocrinol. Metab. 1980; 9: 317, (Part 2)
   PubMedGoogle Scholar
• Benson R. C., Jr., Riggs B. L., Pickard B. M., Arnaud C. D. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am. J. Med. 1974; 56: 821
   PubMed Web of Science ®Google Scholar
• Stewart A., Horst R., Deftos L., Cadman E., et al. A non-parathyroid renotropic factor in humoral hypercalcemia of malignancy. Clin. Res. 1979; 27: 377, (Abstr.)
   Google Scholar
• Sherwood L. M. The multiple causes of hypercalcemia in malignant disease. N. Engl. J. Med. 1980; 303: 1412
   PubMed Web of Science ®Google Scholar
• Ogburn P. L., Black B. M. Primary hyperparathyroidism and papillary carcinoma of the thyroid. Report of four cases. Proc. Staff. Meet., Mayo Clin. 1956; 31: 295
   PubMedGoogle Scholar
• Rose G. A. The radiological diagnosis of osteoporosis. Clin, Radiol. 1964; 15: 75
   PubMedGoogle Scholar
• Hellstrom J. Explorative surgery for suspected hyperparathyroidism. Acta Chir. Scand. 1962; 123: 371
   PubMedGoogle Scholar
• Massaro D., Owen J., Jr. Persistent hypercalcemia associated with bronchogenic carcinoma and primary chief cell hyperplasia of the parathyroids. Am. Rev. Respir. Dis. 1962; 85: 727
   PubMedGoogle Scholar
• Dent C. E., Watson L. Hyperparathyroidism and Cancer. Br. Med. J. 1964; 2: 218
   PubMedGoogle Scholar
• Hellstrom J., Ivemark B. I. Hyperparathyroidism. Clinical and structural findings in 138 cases. Acta. Chir. Scand., (Suppl) 1962; 294: 1
   PubMedGoogle Scholar
• Pyrah L. N., Hodgkinson A., Anderson C. K. Primary hyperparathyroidism—a critical review. Br. J. Surg. 1966; 53: 245
   PubMedGoogle Scholar
• Kaplan L., Katz A. D., Ben-Isaac C., et al. Malignant neoplasms and parathyroid adenoma. Cancer 1971; 28: 401
   PubMed Web of Science ®Google Scholar
• Johanssen H., Werner I. Dysproteinaemia, malignancy and hyperparathyroidism. Ann. Intern. Med. 1975; 83: 121
   Google Scholar
• Drezner M. K., Lebovitz H. E. Primary hyperparathyroidism in paraneoplastic hypercalcemia. Lancet 1978; 1: 1004
   PubMedGoogle Scholar
• Aurbach G. D., Mallette L. E., Patten B. M., et al. Hyperparathyroidism: recent studies. Ann. Intern. Med. 1973; 79: 566
   PubMed Web of Science ®Google Scholar
• Samaan N. A., Hickey R. C., Hill C. S., Jr., Medellin H. 56th Annu. Meet. Endocrine Soc. (Abstract). 1974; A-298
   Google Scholar
• Steiner A. L., Goodman A. D., Powers S. R. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease. Multiple endocrine neoplasia type 2. Medicine (Baltimore) 1968; 47: 371
   PubMed Web of Science ®Google Scholar
• Brereton H. D., Haluschka P. B., Alexander R. W., Mason D. M., Keiser H. R., De Vita V. T., Jr. Indomethacin-responsive hypercalemia in the patient with renal-cell adenocarcinoma. N. Engl. J. Med. 1974; 291: 83
   PubMed Web of Science ®Google Scholar
• Benvenisti D., Goldberg H. Prostaglandins, indomethacin and hypercalcemia in neoplastic disease. N. Engl. J. Med. 1975; 292: 1189
   PubMedGoogle Scholar
• Robertson P. R. Prostaglandins and hypercalcemia of cancer. Med. Clin. North Am. 1981; 65: 845
   PubMedGoogle Scholar
• Seyberth H. W., Raisz L. G., Oates J. A. Prostaglandins and hypercalcemic states. Ann. Rev. Med. 1978; 29: 23
   PubMedGoogle Scholar
• Mundy G. R., Raisz L. G., Cooper R. A., Schecter G. P., Salmon S. E. Evidence of the secretion of an osteoclast stimulating factor in myeloma. N. Engl. J. Med. 1974; 291: 1074
   Google Scholar
• Roberts W. C., Waller B. F. Effect of chronic hypercalcemia on the heart. Am. J. Med. 1981; 71: 371
   PubMed Web of Science ®Google Scholar
• Alfrey A. C., Jenkins D., Groth C. G., Schorr W. S., Gecelter L., Ogden D. A. Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N. Engl. J. Med. 1968; 27: 1349
   Google Scholar
• Kleerekoper M., Ibels L. S., Ingham J. P., McCarthy S. W., Mahony J. F., Stewart J. H., Posen S. Hyperparathyroidism after renal transplantation. Br. Med. J. 1975; 3: 680
   PubMedGoogle Scholar
• Adams P. H., Jowsey J., Kelly P. J., Riggs L., Kinney V. R., Jones J. D. Effects of hyperthyroidism on bone and mineral metabolism in man. Q. J. Med. 1967; 36: 1
   Google Scholar
• Parfitt A. M., Dent C. E. Hyperthyroidism and hypercalcemia. Q. J. Med. 1970; 39: 171
   PubMedGoogle Scholar
• Farnsworth A. E., Dobyns B. M. Hypercalcemia and thyrotoxicosis. Med. J. Aust. 1974; 2: 782
   PubMedGoogle Scholar
• Jones M. K., Papapopulos S. E. Control of hypercalcemia in thyrotoxicosis. Postgrad. Med J. 1979; 55: 891
   PubMedGoogle Scholar
• Lowe C. E., Bird E. D., Thomas W. C. Hypercalcemia in myxoedema. J. Clin. Endocrinol. Metab. 1962; 22: 261
   PubMed Web of Science ®Google Scholar
• Lemberg B. A., Tikkenen M. G. Hypercalcemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy. Br. Med. J. 1981; 283: 461
   PubMedGoogle Scholar
• Stote R. M., Smith L. H., Wilson D. M., Duke W. J., Goldsmith R. S., Arnaud C. D. Hydrochlorothiazide effects on serum calcium and immunoreactive parathyroid hormone concentration. Studies in normal subjects. Ann. Intern. Med. 1972; 77: 587
   PubMed Web of Science ®Google Scholar
• Christiansen C., Baastrup P. C., Transbol I. Lithium induced primary hyperparathyroidism. Calcified Tissue Res. Suppl. 1977; 22: 341
   PubMedGoogle Scholar
• Koppel M. H., Massry S. G., Shinaberger J. H., Hartenbower D. L., Coburn J. W. Thiazide induced rise in serum calcium and magnesium in patients on maintenance dialysis. Ann. Intern. Med. 1970; 72: 895
   PubMed Web of Science ®Google Scholar
• Sode J., Sabol J. J., Meloni C. R., Canaary J. J. Thiazide challenge in primary hyperparathyroidism. Clin. Res. 1969; 17: 550
   Google Scholar
• Belchetz P. E., Cohen R. D., O'Riordan J. L. H., Tomlinson S. Factitious hypercalcemia. Br. Med. J. 1976; 1: 690
   PubMedGoogle Scholar
• Frame B., Jackson G. M., Kleerkoper M., Rao D. S., DeLorenzo A. J. D., Garcia M. Acute severe hypercalcemia a la Munchausen. Am. J. Med. 1981; 70: 316
   PubMedGoogle Scholar
• Christensson T. A. T. Lithium hypercalcemia and hyperparathyroidism. Lancet 1976; 2: 144
   PubMedGoogle Scholar
• Christiansen C., Baastrup P. C., Transbol I. Lithium hypercalcemia, hypermagnesemia and hyperparathyroidism. Lancet 1976; 2: 969
   PubMedGoogle Scholar
• Marx S. J., Spiegel A. M., Levine M. A., Rizzoli R. E., Lasher R. D., Santora A. C., Downs R. W., Aurbach G. D. Familial hypocalciuric hypercalcemia. N. Engl. J. Med. 1982; 307: 416
   PubMed Web of Science ®Google Scholar
• Patterson C. R., Gunn A. Familial benign hypercalcemia. Lancet 1981; 2: 61
   PubMedGoogle Scholar
• Davies M., Klimiuk P. S., Adams P. H., Lumb G. A., Large D. M., Anderson D. C. Familial hypocalcuric hypercalcemia and acute pancreatitis. Br. Med. J. 1981; 282: 1023
   PubMedGoogle Scholar
• Burnett C. H., Commons R. R., Albright F., Howard J. E. Hypercalcemia without hypercalcuria, or hypophosphataemia, calcinosis, and renal insufficiency. N. Engl. J. Med. 1949; 240: 787
   PubMed Web of Science ®Google Scholar
• Wenger J., Kirsner J. B., Palmer W. L. The milk alkali syndrome Hypercalcemia alkalosis and azotaemia following calcium carbonate and milk therapy of peptic ulcer. Gastroenterology 1957; 33: 745
   PubMedGoogle Scholar
• Papapoulos S. E., Clemens T. L., Fraher L. J., Luin I. G., Sandler L. M., O'Riordan J. L. H. 1–25 dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoidosis. Lancet 1979; 1: 627
   PubMed Web of Science ®Google Scholar
• Bell W. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1,25-dihydroxy vitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J. Clin. Invest. 1979; 64: 218
   PubMed Web of Science ®Google Scholar
• Parfitt A. M., Frame B. Corticosteroid-responsive hypercalcemia with elevated serum 1 alpha 25 dihydroxyvitamin D. Ann. Intern. Med. 1980; 93: 440
   PubMedGoogle Scholar
• MacGregor G. A. 1–25 dihydroxycholecalciferol in pathogenesis of hypercalcemic sarcoidosis. Lancet 1979; 1: 1041
   PubMedGoogle Scholar
• Schweitzer V. G., Thompson N. W., Clark K. A., Nishiyama R. H., Bigos S. T. Sarcoidosis hypercalcemia and primary hyperparathyroidism. Am, J. Surg. 1981; 142: 499
   PubMedGoogle Scholar
• Albright F. Case records of Massachusetts General Hospital Case 27461. N. Engl. J. Med. 1941; 225: 789
   Google Scholar
• Lawrence G. D., Loeffler R. G., Martin L. G., Connor T. B. Immobilization hypercalcemia. Some aspects of diagnosis and treatment. J. Bone J. Surg. 1973; 55A: 87
   Google Scholar
• Reifenstein E. C., Albright F. Paget's disease pathology. Physiology and the importance of complications arising from fracture and treatment. N. Engl. J. Med. 1944; 231: 343
   Google Scholar
• Drivas G., Ward M., Kerr D. Immobilization hypercalcemia in patients on regular haemodialysis. Br. Med. J. 1975; 2: 468
   Google Scholar
• Nordin B. E. C., Fraser R. Assessment of urinary phosphate excretion. Lancet 1960; 1: 947
   PubMed Web of Science ®Google Scholar
• Nordin B. E. C., Bulusu L. A modified index of phosphate excretion. Postgrad. Med. J. 1968; 44: 93
   PubMed Web of Science ®Google Scholar
• Patterson C. R. Metabolic Disorders of Bone, 1st ed. Blackwell Scientific, Guildford 1974; 53
   Google Scholar
• Hall R., Anderson J., Smart J. A., Besser M. Fundamental Details of Clinical Endocrinology, 2nd ed. Pitman Medical Press, Bath 1974; 403
   Google Scholar
• Wills M. R., McGowan G. K. Plasma chloride levels in hyperparathyroidism and other hypercalcemic states. Br. Med. J. 1964; 1: 1153
   PubMedGoogle Scholar
• Wills M. R. Value of plasma chloride concentration and acid base status in the differential diagnosis of hyperparathyroidism from other causes of hypercalcemia. J. Clin. Pathol. 1971; 24: 219
   PubMed Web of Science ®Google Scholar
• Dent C. E., Watson L. The hydrocortisone test in primary and tertiary hyperparathyroidism. Lancet 1968; 2: 662
   PubMedGoogle Scholar
• Dent C. E., Harper C. M. Plasma alkaline phosphatase in normal adults and in patients with hyperparathyroidism. Lancet 1962; 1: 559
   PubMed Web of Science ®Google Scholar
• Transbol I. B., Hornum I. B., Hahnemann S., Hasner E., Ohlenschlager H., Diemer H., Lockwood K. Tubular reabsorption of calcium in the differential diagnosis of hypercalcemia. Acta Med. Scand. 1970; 188: 505
   PubMedGoogle Scholar
• Drach G. W., Stanton-King J., Jr. Estimating aberrant homeostasis: variance in serum calcium concentration as an aid in diagnosis of hyperparathyroidism. Clin. Chem. 1970; 16: 792
   PubMedGoogle Scholar
• Broadus A. E., Horst R. L., Lang R., Littledike E. T., Rasmussen H. The importance if circulating 1–25 dihydroxy vitamin D in the pathogenesis of hypercalcuria and renal stone formation in primary hyperparathyroidism. N. Engl. J. Med. 1980; 302: 421
   PubMed Web of Science ®Google Scholar
• Heath H., III, Purnell D. C. Urinary cyclic 3′ 5′ adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. J. Lab. Clin. Med. 1980; 96: 974
   PubMedGoogle Scholar
• Marx S. J., Spiegel A. M., Sharp M. E., Brown E. M., Gardner D. G., Downes R. W., Jr., Attic M. F., Stock J. L. Adenosine 3′ 5′ monophosphate response to parathyroid hormone: familial hypocalcuric hypercalcemia versus typical primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1980; 50: 546
   PubMedGoogle Scholar
• Neelon F. A., Birch B. M., Drezner M., Lebovitz H. E. Urinary Cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism. Lancet 1973; 1: 631
   PubMed Web of Science ®Google Scholar
• Drezner M. K., Neelon F. A., Curtis H. B., Lebovitz H. E. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function. Metabolism. 1976; 25: 1103
   PubMed Web of Science ®Google Scholar
• Broadus A. E., Deftos L. J., Bartter F. C. Effects of the intravenous administration of calcium on nephrogenous cycle AMP. J. Clin. Endocrinol. Metab. 1978; 46: 477
   PubMedGoogle Scholar
• Broadus A. E., Mahaffey J. E., Bartter F. C., Neer R. M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J. Clin. Invest. 1977; 60: 771
   PubMed Web of Science ®Google Scholar
• Torring O., Cavallin M., Low H., Werner S. Urinary cyclic AMP corrected for glomerular filtration rate in the differential diagnosis of hypercalcemia. Acta Med. Scand. 1982; 211: 401
   PubMedGoogle Scholar
• Froeling P. G. A. M., Bijvoet O. L. M. Kidney mediated effects of parathyroid hormone on extracellular homeostasis of calcium, phosphate and acid base balance in man. Neth. Med. J. 1974; 17: 174
   PubMedGoogle Scholar
• Boyd J. C., Lewis J. W., Slatopolsky E., Ladenson J. H. Parathyrin measured concurrently with free or total calcium in the differential diagnosis of hypercalcemia. Clin. Chem. 1981; 27: 574
   PubMed Web of Science ®Google Scholar
• Berson S. A., Yalow R. S., Aurbach G. D., Potts J. T., Jr. Immunoassay of bovine and human parathyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 1963; 49: 613
   PubMed Web of Science ®Google Scholar
• Tashjian A. H., Levine L., Munson J. Immunochemical identification of parathyroid hormone in nonparathyroid neoplasia associated with hypercalcemia. J. Exp. Med. 1964; 119: 467
   PubMed Web of Science ®Google Scholar
• Roof B. S., Carpenter B., Fink D. J., Gordon G. S. Some thoughts on the nature of ectopic parathyroid hormones. Am. J. Med. 1971; 50: 686
   PubMedGoogle Scholar
• Riggs B. L., Arnaud C. D., Reynolds J. C., Smith L. H. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J. Clin. Invest. 1971; 50: 2079
   PubMedGoogle Scholar
• Mayo Medical Laboratories. Communique 1979; 4(4)
   Google Scholar
• Silverman R., Yalow R. S. Heterogeneity of parathyroid hormone. Clinical and physiological complications. J. Clin. Invest. 1973; 52: 1958
   PubMed Web of Science ®Google Scholar
• Arnaud C. D., Goldsmith R. S., Bordier P. J., et al. Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. Am. J. Med. 1974; 56: 785
   PubMed Web of Science ®Google Scholar
• Cohn D. V., MacGregor R. R., Chu L. L. H., et al. Biosynthesis of proparathyroid hormone and parathyroid hormone. Chemistry, physiology and role of calcium in regulation. Am. J. Med. 1974; 56: 767
   Google Scholar
• Kemper B. B., Habener J. F., Mulligan R. C., et al. Pre-proparathyroid hormone: a direct translation product of parathyroid messenger RNA. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 3731
   PubMed Web of Science ®Google Scholar
• Canterbury J. M., Bricker L. A., Levey G. S., et al. Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J. Clin. Invest. 1975; 55: 1245
   PubMedGoogle Scholar
• Hruska K. A., Kopelman R., Rutherford W. E., et al. Metabolism of immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J. Clin. Invest. 1975; 56: 39
   PubMed Web of Science ®Google Scholar
• Canterbury J. M., Reiss E. Multiple immunoreactive molecular forms of parathyroid hormone in human serum. Proc. Soc. Exp. Biol. Med. 1972; 140: 1393
   PubMedGoogle Scholar
• Canterbury J. M., Levey G. S., Reiss E. Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J. Clin. Invest. 1973; 52: 524
   PubMed Web of Science ®Google Scholar
• Goltzman D. Parathyroid hormone and hyperparathyroidism: current concepts. Can. J. Surg. 1978; 21: 285
   PubMedGoogle Scholar
• Juan D. Differential diagnosis of hypercalcemia, A mechanistic approach. Postgrad. Med. 1979; 66(4)72
   PubMed Web of Science ®Google Scholar
• Powell D., Singer F. R., Murray T. M., et al. Non-parathyroid humoral hypercalcemia in patients with neoplastic disease. N. Engl. J. Med. 1973; 289: 176
   PubMed Web of Science ®Google Scholar
• Nissenson R. A., Arnaud C. D. Properties of the parathyroid hormone receptor-adenylate cyclase system in chicken renal plasma membranes. J. Biol. Chem. 1979; 254: 1469
   PubMedGoogle Scholar
• Wong E. T., Freier E. F. The differential diagnosis of hypercalcemia. An algorithm for more effective use of laboratory tests. JAMA 1982; 287: 75
   Google Scholar
• Bayliss P. H., Milles J. J., Wilkinson R., Health D. A. Vasopressin function in hypercalcemia. Clin. Endocrinol. 1981; 15: 343
   PubMedGoogle Scholar
• Worlsman J., Frank S. The Q-T interval in clinical hypercalcemia. Clin. Cardio. 1981; 4: 87
   PubMedGoogle Scholar
• Wills M. R. Laboratory tests in the differentiation of hyperparathyroidism from other causes of hypercalcemia. Ann. Clin. Biochem. 1970; 7: 136
   Google Scholar
• Heinemann H. O. Metabolic alkalosis in patients with hypercalcemia. Metab. Clin. Exp. 1965; 14: 1137
   PubMed Web of Science ®Google Scholar
• Broulik P. D., Pacovsky V. The chloride phosphate ratio as the screening test for primary hyperparathyroidism. Horm. Metab. Res. 1974; 11: 577
   Google Scholar
• Palmer F. J., Nelson J. C., Bacchus H. The chloride phosphate ratio in hypercalcemia. Ann. Intern. Med. 1974; 80: 200
   PubMed Web of Science ®Google Scholar
• Drago J. R., Ronher T. J., Sanford E. J. Diagnosis of hyperparathyroidism. Urology 1976; 7: 4
   PubMedGoogle Scholar
• Reynolds L. R., Flueck J. A. Evaluation of the hypercalcemic patient. Am. Fam. Phys. 1981; 23: 105
   PubMedGoogle Scholar
• Amenta J. S., Harkins M. L. The use of discriminant functions in laboratory medicine. Am. J. Clin. Pathol. 1971; 55: 330
   PubMedGoogle Scholar
• Fraser P., Healey M., Rose M., Watson L. Discriminant functions in differential diagnosis of hypercalcemia. Lancet 1971; 1: 1314
   PubMedGoogle Scholar
• Fraser P., Healey M., Watson L. Further experience with discriminant functions in the differential diagnosis of hypercalcemia. Postgrad. Med. J. 1976; 52: 254
   PubMedGoogle Scholar
• Fraser P., Watson L., Moxham J. Hydrocortisone suppression test and discriminant analysis in differential diagnosis of hypercalcemia. Lancet 1980; 1: 1320
   PubMedGoogle Scholar
• LoCascio V., Cominacini L., Adami S., Galvanini G., Bainchi I., Zanini R., Scruro L. A. Primary hyperparathyroidism. Diagnostic value of a multivariate statistical analysis. La. Ricerca. Clin. Lab. 1976; 6: 267
   PubMedGoogle Scholar
• LoCascio V., Vallaperta P., Adami S., Cominacici L., Galvanini G., Bianchi I., Ferrari M., Scuro L. A. Discriminant analysis in the differential diagnosis of hypercalcemia. Clin. Endocrinol. 1978; 8: 349
   PubMedGoogle Scholar
• Transbol I., Schonau-Jorgensen F., Hornum I., Keiding N. Hypercalcemia discrimination index. A multivariate analysis of parathyroid function in 107 hypercalcemic patients. Acta Endocrinol. 1977; 86: 768
   PubMedGoogle Scholar
• Grero P. S., Hodkinson H. M. Hypercalcemia in elderly hospital in-patients: value of discriminant analysis in differential diagnosis. Age Ageing 1977; 6: 19
   Google Scholar
• Fisken R. A., Heath D. A., Somers S., Bold A. M. Hypercalcemia in hospital patients. Lancet 1981; 1: 202
   PubMedGoogle Scholar
• Holland M. R., Jacobs A. G. On the transportability of linear discriminant functions. Ann. Clin. Biochem. 1982; 19: 47
   PubMedGoogle Scholar
• Elsworth R., Howard J. E. Studies in the physiology of the parathyroid glands. Bull. Johns Hopkins Hosp. 1934; 55: 296
   Google Scholar
• Goldsmith R. S., Fourland M. Rapid calcium infusion test for hyperparathyroidism. Arch. Intern. Med. 1964; 113: 550
   PubMedGoogle Scholar
• Broadus A. E., Horst E. L., Littledyke E. Y., Mahaffey J. E., Rasmussen H. Primary hyperparathyroidism with intermittent hypercalcemia, serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin. Endocrinol. 1980; 12: 225
   PubMed Web of Science ®Google Scholar
• Nilsson O., Almqvist Est, Carlberg B. E. Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man. Acta Med. Scand. 1978; 204: 249
   PubMedGoogle Scholar
• Anderson J., Dent C. E., Harper C., Philpot G. R. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcemia. Possibly antagonistic actions of cortisone and Vitamin D. Lancet 1954; 2: 720
   Google Scholar